Table 2.
Outcome | No consideration for interaction between time and SDC-1 | Interaction between time and SDC-1 | |||||
---|---|---|---|---|---|---|---|
Coefficienta | 95% LCL | 95% UCL | P-value | q-valueb | P-value | q-valueb | |
TP | 0.0012 | − 0.0037 | 0.0061 | 0.638 | 0.729 | 0.362 | 0.482 |
ALB | 0.0015 | − 0.0013 | 0.0042 | 0.289 | 0.385 | 0.111 | 0.198 |
log_CK | 0.0013 | − 0.0017 | 0.0043 | 0.401 | 0.494 | 0.861 | 0.861 |
log_AST | 0.0042 | 0.0018 | 0.0065 | 0.001 | 0.003 | < 0.001 | 0.002 |
log_ALT | 0.0034 | 0.0012 | 0.0057 | 0.003 | 0.009 | < 0.001 | 0.001 |
log_LD | 0.0012 | 0 | 0.0024 | 0.056 | 0.089 | < 0.001 | < 0.001 |
log_ALP | 0.0002 | − 0.0010 | 0.0015 | 0.695 | 0.741 | 0.001 | 0.004 |
log_ChE | − 0.0014 | − 0.0032 | 0.0004 | 0.115 | 0.168 | 0.365 | 0.449 |
log_CRE | 0.0020 | 0.0012 | 0.0028 | < 0.001 | < 0.001 | 0.009 | 0.021 |
log_BUN | 0.0015 | 0.0002 | 0.0028 | 0.019 | 0.044 | 0.018 | 0.037 |
log_TG | 0.0032 | − 0.0455 | 0.0519 | 0.874 | 0.874 | 0.805 | 0.859 |
log_T-Bil | − 0.0026 | − 0.0041 | − 0.0011 | 0.001 | 0.003 | 0.004 | 0.01 |
FDP | 0.1540 | 0.0230 | 0.2850 | 0.021 | 0.038 | 0.336 | 0.489 |
D-dimer | 0.0821 | 0.0135 | 0.1507 | 0.019 | 0.051 | 0.152 | 0.243 |
AT III | − 0.0707 | − 0.1307 | − 0.0107 | 0.021 | 0.042 | 0.694 | 0.793 |
Volume of infusion per day | − 17.8331 | − 25.2211 | − 10.4450 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
All mixed effects models were adjusted for age and sex.
SDC-1 syndecan-1, TP total protein, ALB albumin, CK creatine kinase, AST aspartate aminotransferase, ALT alanine aminotransferase, LD lactate dehydrogenase, ALP alkaline phosphatase, ChE cholinesterase, CRE creatinine, BUN blood urea nitrogen, TG triglyceride, T-Bil total-bilirubin, FDP fibrin degradation product, AT III antithrombin III, LCL lower confidence limit, UCL upper confidence limit.
aCoefficient indicates the increase in the mean value of an outcome when SDC-1 increases by 10.
bThe q-value was calculated using the Benjamini–Hochberg method.